Description  Claims  Drawing  Cited references 

WO0183822A   [0004]  [0004] 
WO00923256A   [0004]  [0004] 
EP1043676A   [0005] 
US20050266444   [0178] 
US20050196799   [0178] 
US20050032095   [0178] 
US20040197774   [0178] 
US20040137473   [0178] 

Cancer Genet. Cytogenet   [0001] 
Int. J. Oncol.   [0001] 
Am. J. Pathol.   [0001] 
Genes Chromosomes Cancer   [0001] 
Am. J. Hum. Genet.   [0001] 
Int.J.Oncol.   [0001] 
Nat.Genet.   [0001] 
Nat. Genet.   [0002] 
Science   [0003] 
J. Pathology   [0003] 
Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation   [0004] 
Med. Hypotheses.   [0006] 
Science   [0049] 
Methods Enzymol.   [0049] 
Mamm. Genome.   [0050] 
Genome Res.   [0050] 
Am. J. Med. Genet. A.   [0051] 
High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.   [0052] 
Clin. Genet.   [0052] 
Curr. Op. Chem. Biol.   [0053] 
Mass Spec. Rev.   [0053] 
Nature   [0053] 
Specific expression of the annexin VIII gene in acute promyelocytic leukemia   [0176] 
Y4 receptor knockout rescues fertility in ob/ob mice   [0176] 
Identification of high risk breast-cancer patients by gene expression profiling   [0178] 
Prognostic relevance of gene amplifications and coamplifications in breast cancer   [0178] 
Profiling breast cancer by array CGH   [0178] 
The genetics and genomics of cancer   [0178] 
Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival   [0178] 
Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival   [0178] 
Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons   [0178] 
A versatile statistical analysis algorithm to detect genome copy number variation   [0178] 
Cancer chromosomes in crisis   [0178] 
Good Old'' clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers   [0178] 
Near tetraploid prostate carcinoma. Methodologic and prognostic aspects   [0178] 
Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma   [0178] 
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes   [0178] 
Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity   [0178] 
A role for common fragile site induction in amplification of human oncogenes   [0178] 
HER-2/neu and topoisomerase IIalpha in breast cancer   [0178] 
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization   [0178] 
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors   [0178] 
Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization   [0178] 
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization   [0178] 
Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group   [0178] 
Improved grading of breast adenocarcinomas based on genomic instability   [0178] 
Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH   [0178] 
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes   [0178] 
Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation   [0178] 
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer   [0178] 
The production of homozygous deficient tissues with mutant characteristics by means of the aberrant mitotic behavior of ring-shaped chromosomes   [0178] 
The stability of broken ends of chromosomes in Zea Mays   [0178] 
HER2 as a prognostic factor in breast cancer   [0178] 
PROBER : oligonucleotide FISH probe design software   [0178] 
Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue   [0178] 
Circular binary segmentation for the analysis of array-based DNA copy number data   [0178] 
Cyclin D1, EMS1 and 11q13 amplification in breast cancer   [0178] 
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer   [0178] 
Molecular portraits of human breast tumours   [0178] 
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors   [0178] 
Comparative genomic hybridization of formalin-fixed, paraffin-enbedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas   [0178] 
Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping   [0178] 
Large-scale copy number polymorphism in the human genome   [0178] 
A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification   [0178] 
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer   [0178] 
Gene expression patterns of carcinomas distinguish tumor subclasses with clinical implications   [0178] 
Breast cancer classification and prognosis based on gene expression profiles from a population-based study   [0178] 
Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification   [0178] 
Molecular cytogenetics of primary breast cancer by CGH   [0178] 
Gene expression profiling predicts clinical outcome of breast cancer   [0178] 
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene   [0178] 
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer   [0178]